keyword
Keywords Anticoagulation and metabolic ...

Anticoagulation and metabolic syndrome

https://read.qxmd.com/read/38609158/disentangling-the-riddle-of-systemic-lupus-erythematosus-with-antiphospholipid-syndrome-blood-transcriptome-analysis-reveals-a-less-pronounced-ifn-signature-and-distinct-molecular-profiles-in-venous-versus-arterial-events
#1
JOURNAL ARTICLE
Dionysis Nikolopoulos, Catherine Loukogiannaki, George Sentis, Panagiotis Garantziotis, Theodora Manolakou, Noemin Kapsala, Myrto Nikoloudaki, Antigone Pieta, Sofia Flouda, Ioannis Parodis, George Bertsias, Antonis Fanouriakis, Anastasia Filia, Dimitrios T Boumpas
INTRODUCTION: Systemic lupus erythematosus with antiphospholipid syndrome (SLE-APS) represents a challenging SLE endotype whose molecular basis remains unknown. METHODS: We analysed whole-blood RNA-sequencing data from 299 patients with SLE (108 SLE-antiphospholipid antibodies (aPL)-positive, including 67 SLE-APS; 191 SLE-aPL-negative) and 72 matched healthy controls (HC). Pathway enrichment analysis, unsupervised weighted gene coexpression network analysis and machine learning were applied to distinguish disease endotypes...
April 12, 2024: Annals of the Rheumatic Diseases
https://read.qxmd.com/read/38534886/drug-drug-interactions-of-fxi-inhibitors-clinical-relevance
#2
REVIEW
Nicola Ferri, Elisa Colombo, Alberto Corsini
Inhibitors of the factor FXI represent a new class of anticoagulant agents that are facing clinical approval for the treatment of acute coronary syndrome (ACS), venous thromboembolism (VTE), and stroke prevention of atrial fibrillation (AF). These new inhibitors include chemical small molecules (asundexian and milvexian), monoclonal antibodies (abelacimab, osocimab, and xisomab), and antisense oligonucleotides (IONIS-FXIRX and fesomersen), and thus, they have very peculiar and different pharmacokinetic and pharmacodynamic properties...
March 21, 2024: Hematology Reports
https://read.qxmd.com/read/38526361/-choice-of-the-prosthetic-valve-in-patients-aged-between-55-and-70-years
#3
JOURNAL ARTICLE
Antonio Salsano, Giulia Parolari, Giacomo Perocchio, Francesco Santini
About 280 000 heart valve replacements are performed worldwide every year. Since the first prosthetic valve implantation in 1952 there have been notable developments. There are a lot of types of prosthetic valves that can be summarized into two categories: biological prosthetic valves or mechanical prosthetic valves. Biological prostheses, made of bovine or porcine pericardium, homografts, or autografts, degenerate over time becoming dysfunctional. Mechanical prostheses have a potentially unlimited lifespan but require oral anticoagulation which can affect patients' quality of life...
April 2024: Giornale Italiano di Cardiologia
https://read.qxmd.com/read/38456903/-drug-therapy-for-arterial-hypertension-and-atrial-fibrillation-in-frail-patients-are-there-any-new-insights-and-recommendations
#4
REVIEW
Ursula Müller-Werdan
The frail and elderly are considered to be at particular risk of suffering an adverse drug reaction. Empirical studies confirm the increased rate of adverse drug reactions. Whether frailty per se impairs drug metabolism or the underlying organ ageing processes and multimorbidity cannot be answered with certainty based on current data. Cardiovascular diseases exhibit a considerable interdependence with frailty. For example, there is a disproportionate syndromal interdependence between heart failure and frailty, and the typical ageing processes of the sinus node can be interpreted as heartbeat frailty...
March 8, 2024: Inn Med (Heidelb)
https://read.qxmd.com/read/38070211/superior-vena-cava-syndrome-in-chronic-intestinal-failure-patients-when-the-going-gets-tough
#5
JOURNAL ARTICLE
V E L M Gillis, J W Korzilius, Y Wouters, S F M Jenniskens, G J A Wanten
BACKGROUND & AIMS: Catheter-related venous thrombosis is a severe complication of home parenteral nutrition (HPN) with potentially devastating consequences such as superior vena cava syndrome (SVCS). Early recognition and awareness of factors leading to its development are of paramount importance. However, studies are lacking in HPN patients focusing on this topic. In this study, we aimed to determine the incidence of SVCS in HPN patients and describe SVCS-related outcomes. METHODS: This retrospective cohort study comprised all adult HPN patients who developed SVCS between 2000 and 2022 at our national HPN referral center...
January 2024: Clinical Nutrition
https://read.qxmd.com/read/37900068/investigating-the-joint-application-of-negative-pressure-wound-treatment-and-tissue-therapy-for-chronic-wounds-in-patients-with-diabetes
#6
JOURNAL ARTICLE
Yulia Ivanova, Svitlana Gramatiuk, Igor Kryvoruchko, Mykhailo Tymchenko, Kyrylo Goltsev, Karine Sargsyan
This study aimed to investigate the effectiveness of combined negative pressure wound therapy (NPWT) and human amniotic membrane in patients with chronic wounds associated with diabetes. A total of five patients with type 2 diabetes, including ischemic and mixed forms of diabetic foot syndrome, presenting with ischemic wounds of the lower extremities were included in this study. Patients with uncorrected limb ischemia were excluded. The treatment protocol included diabetes compensation (treatment with fractional insulin therapy), anticoagulant, metabolic therapy and angiotropic therapy, physical treatment methods, osteoporosis therapy with calcium preparations, and wound-specific interventions...
July 2023: Journal of Medicine and Life
https://read.qxmd.com/read/37895337/the-brain-endothelial-cell-glycocalyx-plays-a-crucial-role-in-the-development-of-enlarged-perivascular-spaces-in-obesity-metabolic-syndrome-and-type-2-diabetes-mellitus
#7
REVIEW
Melvin R Hayden
The brain endothelial cell (BEC) glycocalyx (ecGCx) is a BEC surface coating consisting of a complex interwoven polysaccharide (sweet husk) mesh-like network of membrane-bound proteoglycans, glycoproteins, and glycosaminoglycans (GAGs) covering the apical luminal layer of the brain endothelial cells. The ecGCx may be considered as the first barrier of a tripartite blood-brain barrier (BBB) consisting of (1) ecGCx; (2) BECs; and (3) an extravascular compartment of pericytes, the extracellular matrix, and perivascular astrocytes...
September 24, 2023: Life
https://read.qxmd.com/read/37845766/diabetes-related-phenotypes-and-their-influence-on-outcomes-of-patients-with-corona-virus-disease-2019-covid-19
#8
JOURNAL ARTICLE
Lais Isidoro Alves, Adriana Aparecida Bosco, Adriana Aparecida Rosa, Marcia Regina Soares Correia, Sergio Russo Matioli, Maria Elizabeth Rossi da Silva
INTRODUCTION: Diabetes mellitus (DM) is associated with severe forms of COVID-19 but little is known about the diabetes-related phenotype considering pre-admission, on-admission and data covering the entire hospitalization period. METHODS: We analyzed COVID-19 inpatients (n = 3327) aged 61.2(48.2-71.4) years attended from March to September 2020 in a public hospital. RESULTS: DM group (n = 1218) differed from Non-DM group (n = 2109) by higher age, body mass index (BMI), systolic blood pressure and lower O2 saturation on admission...
October 16, 2023: Diabetology & Metabolic Syndrome
https://read.qxmd.com/read/37844433/a-paradigm-shift-for-cardiovascular-outcome-evaluation-in-diabetes-major-adverse-cardiovascular-events-mace-to-major-adverse-vascular-events-mave
#9
REVIEW
Ashu Rastogi, Anand Sudhayakumar, Nicholas C Scheaper, Edward B Jude
BACKGROUND AND AIMS: Drugs for diabetes are required to demonstrate cardiovascular safety through CV outcome trials (CVOT). The pre-defined end-points for cardiovascular outcome studies may not be sufficient to capture all clinically relevant atherosclerotic cardio vascular disease (ASCVD) events particularly peripheral arterial disease (PAD). METHODS: We planned a scoping review and searched database to identify CVOT conducted in population with diabetes measuring lower limb events due to PAD as the primary outcome measure...
October 12, 2023: Diabetes & Metabolic Syndrome
https://read.qxmd.com/read/37821982/the-relevance-of-the-non-invasive-biomarkers-lncrna-gas5-mir-21-cerna-regulatory-network-in-the-early-identification-of-diabetes-and-diabetic-nephropathy
#10
JOURNAL ARTICLE
He Sun, Tong Chen, Xin Li, Yonghong Zhu, Shuang Zhang, Ping He, Yali Peng, Qiuling Fan
BACKGROUND: To investigate the diagnostic value of serum lncRNA growth arrest-specific transcript 5 (lncRNA GAS5) and microRNA-21 (miR-21) in patients with type 2 diabetes mellitus (T2DM) and diabetic nephropathy (DN), and elucidate their roles in the pathogenesis. METHODS: A microarray technology was used asses lncRNA GAS5 and miR-21 expression profiles in non-anticoagulant blood from 44 patients including T2DM without DN group (DM), T2DM with DN group (DN), and healthy controls group (N), followed by real-time PCR validation...
October 11, 2023: Diabetology & Metabolic Syndrome
https://read.qxmd.com/read/37776692/one-year-clinical-outcomes-of-bivalirudin-versus-unfractionated-heparin-in-patients-with-type-2-diabetes-undergoing-elective-percutaneous-coronary-intervention
#11
JOURNAL ARTICLE
Yulong Li, Jiawen Li, Changdong Guan, Shuhong Su, Zhifang Wang, Haiwei Liu, Yuejin Yang, Runlin Gao, Jinqing Yuan, Xueyan Zhao
BACKGROUND: Patients with diabetes and coronary artery disease have a higher risk of bleeding and thrombotic events. However, data on the safety and efficacy of bivalirudin in these patients undergoing elective percutaneous coronary intervention (PCI) are lacking. METHODS: 1152 patients undergoing elective PCI anticoagulated with bivalirudin and 10,250 patients anticoagulated with unfractionated heparin (UFH) (with or without glycoprotein IIb/IIIa inhibitors [GPI]) were performed propensity-score matching method...
September 20, 2023: Diabetes & Metabolic Syndrome
https://read.qxmd.com/read/37661277/acute-kidney-injury-in-neurocritical-care
#12
REVIEW
Faeq Husain-Syed, Tomonori Takeuchi, Javier A Neyra, Gonzalo Ramírez-Guerrero, Mitchell H Rosner, Claudio Ronco, Ashita J Tolwani
Approximately 20% of patients with acute brain injury (ABI) also experience acute kidney injury (AKI), which worsens their outcomes. The metabolic and inflammatory changes associated with AKI likely contribute to prolonged brain injury and edema. As a result, recognizing its presence is important for effectively managing ABI and its sequelae. This review discusses the occurrence and effects of AKI in critically ill adults with neurological conditions, outlines potential mechanisms connecting AKI and ABI progression, and highlights AKI management principles...
September 3, 2023: Critical Care: the Official Journal of the Critical Care Forum
https://read.qxmd.com/read/37560062/beer-gut-microbiome-alliance-a-discussion-of-beer-mediated-immunomodulation-via-the-gut-microbiome
#13
REVIEW
Silu Zhang, Shuo Jin, Cui Zhang, Shumin Hu, Huajun Li
As a long-established fermented beverage, beer is rich in many essential amino acids, vitamins, trace elements, and bioactive substances that are involved in the regulation of many human physiological functions. The polyphenols in the malt and hops of beer are also important active compounds that interact in both directions with the gut microbiome. This review summarizes the mechanisms by which polyphenols, fiber, and other beneficial components of beer are fermentatively broken down by the intestinal microbiome to initiate the mucosal immune barrier and thus participate in immune regulation...
2023: Frontiers in Nutrition
https://read.qxmd.com/read/37436639/primary-adrenal-insufficiency-due-to-bilateral-adrenal-hemorrhage-adrenal-infarction-in-a-patient-with-systemic-lupus-erythematosus-and-antiphospholipid-syndrome-case-presentation-and-review-of-the-literature
#14
REVIEW
K Bouki, V Venetsanaki, M Chrysoulaki, A Pateromichelaki, G Betsi, V Daraki, N Sbyrakis, K Spanakis, G Bertsias, P I Sidiropoulos, Paraskevi Xekouki
Primary adrenal insufficiency (PAI) is a rare disease which represents the end stage of a destructive process involving the adrenal cortex. Occasionally it may be caused by bilateral adrenal hemorrhagic infarction in patients with antiphospholipid syndrome (APS). We herein report the challenging case of a 30-year-old female patient with systemic lupus erythematosus (SLE) and secondary APS who was admitted to the emergency department (ED) due to fever, lethargy, and syncopal episodes. Hyponatremia, hyperkalemia, hyperpigmentation, shock, altered mental status, and clinical response to glucocorticoid administration were features highly suggestive of an acute adrenal crisis...
September 2023: Hormones: International Journal of Endocrinology and Metabolism
https://read.qxmd.com/read/37212158/penile-and-digital-calciphylaxis-a-case-report-and-literature-review
#15
JOURNAL ARTICLE
Gonçalo Ávila, Patrícia Matias, Ivo Laranjinha, Ana Carina Ferreira, Célia Gil, Aníbal Ferreira
Calcific uremic arteriolopathy (CUA) represents a rare but severe disease with high morbimortality. The authors present the case of a 58-year-old male patient with chronic kidney disease due to obstructive uropathy, on hemodialysis (HD). He started HD due to uremic syndrome with a severe renal dysfunction, dysregulation of calcium and phosphate metabolism, and he presented with distal penile ischemia, which was treated with surgical debridement and hyperbaric oxygen therapy. Four months later, painful distal digital necrosis of both hands was observed...
May 22, 2023: Clinical Nephrology
https://read.qxmd.com/read/37110152/effects-of-hypolipidemic-drugs-on-psoriasis
#16
REVIEW
Mateusz Matwiejuk, Hanna Mysliwiec, Olivia Jakubowicz-Zalewska, Adrian Chabowski, Iwona Flisiak
Psoriasis is a chronic, systematic, inflammatory disease in which multiple metabolic and immunologic disturbances lead to lipid abnormalities, impaired glucose tolerance, metabolic syndrome, diabetes mellitus, atherosclerosis, hypertension, ischemic heart disease, and numerous metabolic disorders. In clinical practice, the most commonly used drugs in the treatment of lipid abnormalities are statins and fibrates. Statins are characterized by pleiotropic effects such as antioxidant, anti-inflammatory, anticoagulant, and antiproliferative...
March 29, 2023: Metabolites
https://read.qxmd.com/read/37006867/complexity-of-inflammation-in-the-trajectory-of-vascular-disease-interleukin-6-and-beyond
#17
JOURNAL ARTICLE
Motoaki Sano
Takayasu's arteritis, first described by Dr. Mikito Takayasu in 1908, is a systemic vasculitis that mostly affects the aorta and its major branches. Although the etiology of the disease is yet unknown, genetic and environmental factors may both play a role. One hundred years after the discovery of Takayasu's arteritis, inflammation is finally widely recognized as a fundamental condition common to all vascular diseases, and clinical trials have proven the efficacy of molecularly targeted drugs that block each step of the NLRP3 inflammasome/interleukin (IL)-1β/IL-6 cascade in patients with atherosclerotic vascular disease and elevated C-reactive protein (CRP)...
March 25, 2023: Annals of Vascular Diseases
https://read.qxmd.com/read/36963818/metabolic-syndrome-and-ischaemic-stroke-in-non-anticoagulated-atrial-fibrillation-with-low-cha-2-ds-2-vasc-scores
#18
JOURNAL ARTICLE
Hyo-Jeong Ahn, So-Ryoung Lee, Eue-Keun Choi, Seung-Woo Lee, Kyung-Do Han, Soonil Kwon, Seil Oh, Gregory Y H Lip
OBJECTIVE: Conflicting results have been reported on whether metabolic syndrome (MetS) confers an increased risk of ischaemic stroke in atrial fibrillation (AF). We investigated the risk of ischaemic stroke according to MetS in patients with AF who are not indicated for oral anticoagulants. METHODS: A total of 76 015 oral anticoagulant-naïve patients with AF with low Congestive Heart Failure, Hypertension, Age ≥75 years (Doubled), Diabetes Mellitus, Stroke (Doubled), Vascular Disease, Age 65-74 years, Sex Category (Female) (CHA2 DS2 -VASc) score (0 and 1) were included from the National Health Information Database...
March 24, 2023: Heart
https://read.qxmd.com/read/36344732/-cardiovascular-risk-factors-haemostasis-and-antithrombotic-treatment-in-retinal-vessel-occlusion
#19
REVIEW
Claudia Kuhli-Hattenbach, Christoph Sucker, Nicolas Feltgen, Martin Spitzer, Maximilian Schultheiss, Lars-Olof Hattenbach
Venous and arterial retinal vascular occlusions are age-related disorders, generally associated with classical cardiovascular risk factors, rather than an isolated ocular disease. As affected patients often also have an increased general risk for other vascular diseases, such as ischemic stroke, an interdisciplinary clarification of cardiovascular risk factors and systemic comorbidities is essential for all patients. Extended hemostaseological investigations may be recommended in those patients who do not match the typical risk profile...
November 2022: Ophthalmologie
https://read.qxmd.com/read/36308911/prevalence-of-silent-atrial-fibrillation-and-cardiovascular-disease-in-patients-with-obstructive-sleep-apnea
#20
JOURNAL ARTICLE
Anna Højager, Mikkel M Schoos, Peter K Tingsgaard, Troels G Bock, Preben Homøe
OBJECTIVE: Patients with silent and undiagnosed atrial fibrillation (AF) have increased risk of ischemic stroke. Patients with obstructive sleep apnea (OSA) have an increased risk of both AF and ischemic stroke. Our aim was to investigate the prevalence of silent AF and associated risk factors in patients investigated for OSA or with known OSA. METHODS: This prospective observational study was performed in two sites; one outpatient sleep-clinic at Zealand University Hospital and one private Ear-Nose- and Throat clinic...
October 7, 2022: Sleep Medicine
keyword
keyword
23993
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.